BRPI1013328A2 - 4-amino-benzoil-2-(fenilamino) tiofeno-3-carbonitrilas substituídas e 4-a-mino-5benzoil-2-(fenilamino) tiofeno-3-carboxamidas substituídas como inibidores da polimerização de tubulina - Google Patents

4-amino-benzoil-2-(fenilamino) tiofeno-3-carbonitrilas substituídas e 4-a-mino-5benzoil-2-(fenilamino) tiofeno-3-carboxamidas substituídas como inibidores da polimerização de tubulina

Info

Publication number
BRPI1013328A2
BRPI1013328A2 BRPI1013328A BRPI1013328A BRPI1013328A2 BR PI1013328 A2 BRPI1013328 A2 BR PI1013328A2 BR PI1013328 A BRPI1013328 A BR PI1013328A BR PI1013328 A BRPI1013328 A BR PI1013328A BR PI1013328 A2 BRPI1013328 A2 BR PI1013328A2
Authority
BR
Brazil
Prior art keywords
phenylamino
thiophene
substituted
5benzoyl
carbonitriles
Prior art date
Application number
BRPI1013328A
Other languages
English (en)
Inventor
Hua Xu
Komath V Damodaran
Paul P Beroza
Stella Lui
Wenli Ma
Zhuo Wang
Original Assignee
Telik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Telik Inc filed Critical Telik Inc
Publication of BRPI1013328A2 publication Critical patent/BRPI1013328A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/08Hydrogen atoms or radicals containing only hydrogen and carbon atoms
    • C07D333/10Thiophene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI1013328A 2009-04-16 2010-02-09 4-amino-benzoil-2-(fenilamino) tiofeno-3-carbonitrilas substituídas e 4-a-mino-5benzoil-2-(fenilamino) tiofeno-3-carboxamidas substituídas como inibidores da polimerização de tubulina BRPI1013328A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16978509P 2009-04-16 2009-04-16
PCT/US2010/023561 WO2010120400A2 (en) 2009-04-16 2010-02-09 Substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carbonitriles and substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carboxamides as tubulin polymerization inhibitors

Publications (1)

Publication Number Publication Date
BRPI1013328A2 true BRPI1013328A2 (pt) 2016-03-29

Family

ID=42983059

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1013328A BRPI1013328A2 (pt) 2009-04-16 2010-02-09 4-amino-benzoil-2-(fenilamino) tiofeno-3-carbonitrilas substituídas e 4-a-mino-5benzoil-2-(fenilamino) tiofeno-3-carboxamidas substituídas como inibidores da polimerização de tubulina

Country Status (12)

Country Link
US (1) US8410163B2 (pt)
EP (1) EP2419424A4 (pt)
JP (1) JP2012524066A (pt)
KR (1) KR20120006543A (pt)
CN (1) CN102395581A (pt)
AU (1) AU2010236980A1 (pt)
BR (1) BRPI1013328A2 (pt)
CA (1) CA2757573A1 (pt)
IL (1) IL215552A0 (pt)
SG (1) SG175198A1 (pt)
WO (1) WO2010120400A2 (pt)
ZA (1) ZA201107487B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103768595B (zh) * 2014-01-27 2016-03-02 中国医学科学院医学生物学研究所 唑来膦酸佐剂及含唑来膦酸佐剂的疫苗
WO2017181974A1 (zh) * 2016-04-20 2017-10-26 苏州苏领生物医药有限公司 五元杂环类化合物及其制备方法、药物组合物和用途
CN107304202A (zh) * 2016-04-20 2017-10-31 苏州苏领生物医药有限公司 五元杂环类化合物及其制备方法、药物组合物和用途
CN108358864B (zh) * 2017-12-15 2020-07-17 五邑大学 一种2-酰基-5-苯基噁唑类微管蛋白抑制剂的制备方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2269520C2 (ru) * 2000-05-09 2006-02-10 Эдфарма, Инк. Соединения пиперазиндиона
AUPR283801A0 (en) * 2001-02-01 2001-03-01 Australian National University, The Chemical compounds and methods
SE0102616D0 (sv) * 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
MXPA04004064A (es) * 2001-10-30 2004-09-06 Pharmacia Corp Derivados heteroaromaticos de carboxamida para el tratramiento de la inflamacion.
US20050085531A1 (en) 2003-10-03 2005-04-21 Hodge Carl N. Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
WO2006078287A2 (en) 2004-05-06 2006-07-27 Plexxikon, Inc. Pde4b inhibitors and uses therefor

Also Published As

Publication number Publication date
US20120101286A1 (en) 2012-04-26
JP2012524066A (ja) 2012-10-11
SG175198A1 (en) 2011-12-29
ZA201107487B (en) 2012-06-27
EP2419424A4 (en) 2014-01-08
WO2010120400A2 (en) 2010-10-21
KR20120006543A (ko) 2012-01-18
CN102395581A (zh) 2012-03-28
CA2757573A1 (en) 2010-10-21
WO2010120400A3 (en) 2011-01-20
AU2010236980A1 (en) 2011-11-10
US8410163B2 (en) 2013-04-02
EP2419424A2 (en) 2012-02-22
IL215552A0 (en) 2011-12-29

Similar Documents

Publication Publication Date Title
DOP2012000114A (es) Inhibidor bromodominio de benzodiazepina
BRPI1015238A2 (pt) diamidas de azetidilina como inibidores de monoaciglicerol lipase
BR112013009496A2 (pt) artigos absorventes e métodos de fabricação dos mesmos
CR20130192A (es) Derivados de bencimidazol como inhibidores de cinasa p13
BR112013013167A2 (pt) inibidores de bromodomínio e usos dos mesmos
BR112012000525A2 (pt) inibidores da bace
BRPI1008029A2 (pt) dispositivo de exibição e método de fabricação do mesmo
BR112012015827A2 (pt) novos compostos de pirimidina como inibidores de mtor e p13k
BRPI1008744A2 (pt) hidrotratamento de caboidratos
BR112013008886A2 (pt) pirrolidinonas como inibidores de metap-2
UY33155A (es) Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa
FI20096058A0 (fi) Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä
BR112012025149A2 (pt) artigo absorvente e método de fabricação de um artigo absorvente
BR112012010201A2 (pt) formulação de libertação modificada da lacosamida
ECSP10010558A (es) Tiazolopiridin-2-iloxi-fenil y tiazolopirazin-2-iloxi-fenil aminas como moduladores de la leucotrieno a4 hidrolasa
DK3597650T3 (da) Aldosereduktasehæmmere og anvendelser deraf
BR112012014277A2 (pt) fabricação e montagem de artigos absorventes com múltiplos componentes impressos
BRPI1014683A2 (pt) marcador e stent
DK2516435T3 (da) Inhibitorer af AKT-aktivitet
BRPI1006486A2 (pt) dispositivo e método de localizar de descargas parciais
ECSP12011970A (es) NUEVOS DERIVADOS DE (HETEROCICLO-PIPERIDINA CONDENSADA)-(PIPERAZINIL)-1-ALCANONA O DE (HETEROCICLO-PIRROLIDINA CONDENSADA)-(PIPERAZINIL)-1-ALCANONA Y SU UTILIZACIÓN COMO INHIBIDORES DE p75
BR112012003584A2 (pt) método e disposito para utilização de biomassa
BRPI1009132A2 (pt) derivados de rosuvastatina e atorvastatina
BRPI1013328A2 (pt) 4-amino-benzoil-2-(fenilamino) tiofeno-3-carbonitrilas substituídas e 4-a-mino-5benzoil-2-(fenilamino) tiofeno-3-carboxamidas substituídas como inibidores da polimerização de tubulina
BR112012009858A2 (pt) conjunto de um primeiro equipamento e de um segundo equipamento

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A E 6A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2367 DE 17-05-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.